Buscar
01/11/2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy
Cheng, AYY, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, MA, Bonnemaire, M, Melas-Melt, L, Mimouni, S, Davies, M. A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 217DOI:10.1016/j.diabres.2024.111871. PMID:39343145. IF:7.400(Q1/1D).
10/10/2024
The expression of VDACs and Bcl2 family genes in pituitary adenomas: clinical correlations and postsurgical outcomes
Facundo, AN, Magalhaes, M, Nascimento, GC, Azulay, RS, Santos, RM, Freitas, LA, Nascimento, AGPAC, Rodrigues, VP, Santos, WC, Beckman, AMGS, Abreu, JMF, Silva, RP, Carneiro, EL, Neto, CPO, da Costa, RMG, Corcoy, R, Mato, E, Faria, MS. The expression of VDACs and Bcl2 family genes in pituitary adenomas: clinical correlations and postsurgical outcomes. Frontiers in Endocrinology. 2024; 15DOI:10.3389/fendo.2024.1481050. PMID:39449743. IF:4.600(Q1/3D).
01/10/2024
Cardiometabolic effects of weight loss
Genua, I, Sardà, H, Pérez, A. Cardiometabolic effects of weight loss. Atencion Primaria. 2024; 56(10)DOI:10.1016/j.aprim.2024.102953. PMID:38705132. IF:1.600(Q2/4D).
13/09/2024
GLP-1 receptor agonists in clinical practice
Pérez, A. GLP-1 receptor agonists in clinical practice. MEDICINA CLINICA. 2024; 163(5)DOI:10.1016/j.medcli.2024.02.018. PMID:38688736. IF:2.100(Q2/3D).